That is, depending upon the type of DNA-damaging cancer treatment chosen, levels of functional REV1 may help enhance the efficacy of the said drug, as would be the case for chemotherapy treatment that causes chemical modifications to DNA, where REV1 contributes to mutagenesis and consequent therapy resistance. The gene discussed is REV1; the disease is cancer.